A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones

Title:A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones

Volume: 18 Issue: 10

Author(s): Letitia Meiring, Jacobus P. Petzer and Anel Petzer*

Affiliation:

• Pharmaceutical Chemistry, School of Pharmacy and Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520,south africa

Keywords: Aripiprazole, carteolol, cilostazol, 3, 4-dihydro-2(1H)-quinolinone, pharmacology, drug design.

Abstract: The 3,4-dihydro-2(1H)-quinolinone moiety is present in a number of pharmacologically active compounds. These include FDA approved drugs such as cilostazol, carteolol and aripiprazole as well as numerous experimental compounds. Compounds containing the 3,4-dihydro-2(1H)-quinolinone moiety also exhibit a variety of activities in both the peripheral and central tissues, which includes phosphodiesterase inhibition, blocking of β-adrenergic receptors, antagonism of vasopressin receptors and interaction with serotonin and dopamine receptors. Based on its versatility in drug design and action, this paper reviews the pharmacological actions of compounds containing the 3,4-dihydro-2(1H)- quinolinone scaffold with emphasis being placed on the most important and significant members of each activity class.

Cite this article as:

Meiring Letitia , Petzer P. Jacobus and Petzer Anel*, A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones, Mini-Reviews in Medicinal Chemistry 2018; 18 (10) . https://dx.doi.org/10.2174/1389557517666170927141323